TURBt治疗高危高龄浸润性膀胱癌的临床观察

Clinical observation of TURBt in the treatment of high-risk invasive bladder cancer at advanced age

目的观察TURBt治疗高龄浸润性膀胱癌的临床效果。方法选取我院2010年8月~2016年7月收治的的45例高龄浸润性膀胱癌患者,将其分为两组。对照组(22例)患者实施常规治疗,观察组(23例)患者实施TURBt治疗。比较两组患者治疗后的总并发症发生率、手术时间、术中出血量、住院时间。结果观察组患者的总并发症发生率为8.70%,低于对照组的40.91%(P<0.05),手术时间为(51.45±1.18)min,住院时间为(9.36±1.08)d,短于对照组的(65.34±1.17)min、(15.45±0.27)d,术中出血量为(105.45±10.11)ml,少于对照组的(129.78±12.45)ml(P<0.05)。结论对高龄浸润性膀胱癌患者实施TURBt治疗,能取得十分显著的效果,能延长患者的生命,值得临床进一步推广和应用。

Objective To observe the clinical effect of TURBt in the treatment of invasive bladder cancer at advanced age.Methods From August 2010 to July 2016,45 elderly patients with invasive bladder cancer treated in our hospital were enrolled and divided into the two groups.In the control group （n=22）,patients were provided with routine treatment, while in the observation group （n=23）,they were treated with TURBt.The total incidence of complications,operation time, intraoperative blood loss,and hospital stay were compared between the two groups.Results The total incidence of complications of the observation group was 8.70%,which was lower than that of the control group （40.91%） （P〈0.05）,the operation time was （51.45±1.18） min,the hospital stay was （9.36±1.08） d,which was shouter than those of the control group [（65.34±1.17） min,（15.45±0.27） d] respectively,and intraoperative amount of bleeding was （105.45±0.11） ml was fewer than that of the control group [（129.78±12.45） ml] （P〈0.05）.Conclusion For elderly patients with invasive bladder cancer,application of TURBt can obtain a remarkable effect and prolong these patients＇ life,which is worthy of further promotion and application in clinic.